Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial Cancer

ClinicalTrials.gov ID: NCT00071929

Public ClinicalTrials.gov record NCT00071929. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 8:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase II Evaluation of Oxaliplatin in the Treatment of Recurrent or Persistent Endometrial Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy, such as oxaliplatin, work in different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have persistent or recurrent endometrial cancer.

Study identification

NCT ID
NCT00071929
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Gynecologic Oncology Group
Network
Enrollment
Not listed

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1999 (Type not available)
Primary completion
Not listed
Completion
Sep 2007 (Actual)
Last update posted
Jun 24, 2013

1999 – 2007

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
36
Facility City State ZIP Site status
University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama 35294-3300 —
CCOP - Western Regional, Arizona Phoenix Arizona 85006-2726 —
Chao Family Comprehensive Cancer Center at University of California Irvine Cancer Center Orange California 92868 —
University of Colorado Cancer Center at University of Colorado Health Sciences Center Denver Colorado 80010 —
New Britain General Hospital New Britain Connecticut 06052 —
CCOP - Christiana Care Health Services Newark Delaware 19713 —
MBCCOP - University of Illinois at Chicago Chicago Illinois 60612 —
University of Chicago Cancer Research Center Chicago Illinois 60637-1470 —
CCOP - Central Illinois Decatur Illinois 62794-9640 —
CCOP - Evanston Evanston Illinois 60201 —
CCOP - Carle Cancer Center Urbana Illinois 61801 —
Saint Joseph Regional Medical Center South Bend Indiana 46617 —
Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center Kansas City Kansas 66160-7357 —
CCOP - Michigan Cancer Research Consortium Ann Arbor Michigan 48106 —
CCOP - Grand Rapids Grand Rapids Michigan 49503 —
CCOP - Kalamazoo Kalamazoo Michigan 49007-3731 —
CCOP - Metro-Minnesota Saint Louis Park Minnesota 55416 —
University of Mississippi Medical Center Jackson Mississippi 39216-4505 —
Ellis Fischel Cancer Center at University of Missouri - Columbia Columbia Missouri 65203 —
CCOP - Kansas City Kansas City Missouri 64131 —
CCOP - Cancer Research for the Ozarks Springfield Missouri 65807 —
CCOP - Missouri Valley Cancer Consortium Omaha Nebraska 68106 —
SUNY Downstate Medical Center Brooklyn New York 11203 —
Long Island Cancer Center at Stony Brook University Hospital Stony Brook New York 11790-7775 —
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295 —
Ireland Cancer Center Cleveland Ohio 44106 —
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44124 —
Mount Carmel West Hospital Columbus Ohio 43222 —
University of Oklahoma College of Medicine Oklahoma City Oklahoma 73190 —
CCOP - Columbia River Oncology Program Portland Oregon 97225 —
Abington Memorial Hospital Abington Pennsylvania 19001-3788 —
CCOP - Geisinger Clinic and Medical Center Danville Pennsylvania 17822-2001 —
Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey Pennsylvania 17033-0850 —
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 —
Magee-Womens Hospital Pittsburgh Pennsylvania 15213-3180 —
Southeast Gynecologic Oncology Associates Knoxville Tennessee 37917 —
Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville Tennessee 37232-2516 —
CCOP - Scott and White Hospital Temple Texas 76508 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00071929, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2013 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00071929 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →